National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 6) (PB 75 of 2015) (Cth)

PB 75 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 6)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated          29        July 2015

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 6).

   (2)   This Determination may also be cited as PB 75 of 2015.

2. Commencement

   This Determination commences on 1 August 2015.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Calcium

Omit

Canagliflozin

[2]     Schedule 1, after item dealing with Ciclesonide

Omit

Cinacalcet

[3]     Schedule 1, after item dealing with Nystatin

Insert

Obinutuzumab

[4]     Schedule 1, after item dealing with Poly-L-Lactic acid

Omit

Polythylene glycol 400 with propylene glycol

Insert

Polyethylene Glycol 400 with Propylene Glycol

Insert

Pomalidomide

[5]     Schedule 1, after item dealing with Propantheline

Omit

Propranolol

[6]     Schedule 1, after item dealing with Toremifene

Insert

Trametinib

[7]     Schedule 1, after item dealing with Varenicline

Insert

Vedolizumab

[8]     Schedule 2, after item dealing with Prochlorperazine

Insert

Propranolol